Product Description: KM02894 is an inhibitor of glutamate release. Cancer cells release high levels of glutamate, which disrupts normal bone turnover and may lead to cancer-induced bone pain. KM02894 can be used for cancer related research[1].
Applications: Cancer-programmed cell death
Formula: C7H9N3OS2
References: [1]Fazzari J, et.al. Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain. Sci Rep. 2015 Feb 11;5:8380.
CAS Number: 116850-74-9
Molecular Weight: 215.30
Compound Purity: 99.31
Research Area: Cancer
Solubility: DMSO : 25 mg/mL (ultrasonic;warming;heat to 60°C)/DMSO : 33.33 mg/mL (ultrasonic;warming;heat to 60°C)